{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:20:56Z","timestamp":1791123656825,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft, Center for Molecular Medicine Cologne, Families of SMA, Initiative Forschung und Therapie f\u00fcr SMA, SMA Foundation"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Genetics & Development"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.gde.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T07:46:16Z","timestamp":1366271176000},"page":"330-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches"],"prefix":"10.1016","volume":"23","author":[{"given":"Brunhilde","family":"Wirth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Garbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Riessland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gde.2013.03.003_bib0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2796.2011.02502.x","article-title":"Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers","volume":"271","author":"Barnes","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.gde.2013.03.003_bib0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00439-008-0560-2","article-title":"Identifying modifier genes of monogenic disease: strategies and difficulties","volume":"124","author":"Genin","year":"2008","journal-title":"Hum Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.gde.2010.12.007","article-title":"Genetic modifiers of neurological disease","volume":"21","author":"Kearney","year":"2011","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.gde.2013.03.003_bib0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.2010.05879.x","article-title":"Modifier genes in Mendelian disorders: the example of cystic fibrosis","volume":"1214","author":"Cutting","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.gde.2013.03.003_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1749-6632.2010.05821.x","article-title":"Modifier genes in Mendelian disorders: the example of hemoglobin disorders","volume":"1214","author":"Sankaran","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.gde.2013.03.003_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-genet-110410-132512","article-title":"Genetic and epigenetic networks in intellectual disabilities","volume":"45","author":"van Bokhoven","year":"2011","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.gde.2013.03.003_sbref0035","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldkotter","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2013.03.003_sbref0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.gde.2013.03.003_bib0045","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","article-title":"Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number","volume":"119","author":"Wirth","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0050","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1093\/hmg\/ddq147","article-title":"Spinal muscular atrophy: mechanisms and therapeutic strategies","volume":"19","author":"Lorson","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0055","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1086\/302369","article-title":"Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype\u2013phenotype correlation, and implications for genetic counseling","volume":"64","author":"Wirth","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0060","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/gtmb.2010.0253","article-title":"Accuracy of marker analysis quantitative real-time polymerase chain reaction, and multiple ligation-dependent probe amplification to determine SMN2 copy number in patients with spinal muscular atrophy","volume":"15","author":"Alias","year":"2011","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.gde.2013.03.003_bib0065","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jmg.2009.066969","article-title":"Differences in SMN1 allele frequencies among ethnic groups within North America","volume":"46","author":"Hendrickson","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s004390100473","article-title":"SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens","volume":"108","author":"Rochette","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0075","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1086\/301608","article-title":"De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling","volume":"61","author":"Wirth","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(\u2212\/\u2212) mice and results in a mouse with spinal muscular atrophy","volume":"9","author":"Monani","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_sbref0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2013.03.003_sbref0090","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2013.03.003_sbref0095","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1155085","article-title":"Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy","volume":"320","author":"Oprea","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.gde.2013.03.003_bib0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1741-7015-10-24","article-title":"Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy","volume":"10","author":"Bowerman","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.gde.2013.03.003_sbref0105","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1101\/gad.197418.112","article-title":"TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals","volume":"26","author":"Sahashi","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.gde.2013.03.003_sbref0110","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1093\/hmg\/dds263","article-title":"Hypoxia is a modifier of SMN2 splicing and disease severity in a severe SMA mouse model","volume":"21","author":"Bebee","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.21449","article-title":"Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition","volume":"64","author":"Narver","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2013.03.003_bib0120","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0883073807305788","article-title":"Consensus statement for standard of care in spinal muscular atrophy","volume":"22","author":"Wang","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.gde.2013.03.003_sbref0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2012.09.012","article-title":"An SMN-dependent U12 splicing event essential for motor circuit function","volume":"151","author":"Lotti","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.gde.2013.03.003_sbref0130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.neuron.2010.12.032","article-title":"Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy","volume":"69","author":"Mentis","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2013.03.003_sbref0135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cell.2012.09.011","article-title":"SMN is required for sensory-motor circuit function in Drosophila","volume":"151","author":"Imlach","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.gde.2013.03.003_bib0140","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/jmg.2008.057950","article-title":"Congenital heart disease is a feature of severe infantile spinal muscular atrophy","volume":"45","author":"Rudnik-Schoneborn","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.gde.2013.03.003_sbref0145","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/hmg\/ddq330","article-title":"Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice","volume":"19","author":"Heier","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.23582","article-title":"Glucose metabolism and pancreatic defects in spinal muscular atrophy","volume":"72","author":"Bowerman","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2013.03.003_bib0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nbd.2010.01.006","article-title":"Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy","volume":"38","author":"Michaud","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.gde.2013.03.003_sbref0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.gde.2013.03.003_sbref0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.gde.2013.03.003_bib0170","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ana.20836","article-title":"In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate","volume":"59","author":"Brichta","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2013.03.003_bib0175","doi-asserted-by":"crossref","first-page":"e12140","DOI":"10.1371\/journal.pone.0012140","article-title":"SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy","volume":"5","author":"Swoboda","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gde.2013.03.003_bib0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy","volume":"3","author":"Crawford","year":"1996","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.gde.2013.03.003_bib0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-540-34449-0_6","article-title":"Spinal muscular atrophy and therapeutic prospects","volume":"44","author":"Wirth","year":"2006","journal-title":"Prog Mol Subcell Biol"},{"key":"10.1016\/j.gde.2013.03.003_bib0190","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2741\/3670","article-title":"Splicing regulation of the survival motor neuron genes and implications for treatment of spinal muscular atrophy","volume":"15","author":"Bebee","year":"2010","journal-title":"Front Biosci"},{"key":"10.1016\/j.gde.2013.03.003_bib0195","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","article-title":"A positive modifier of spinal muscular atrophy in the SMN2 gene","volume":"85","author":"Prior","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0200","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4161\/rna.7.4.12206","article-title":"Repair of pre-mRNA splicing: prospects for a therapy for spinal muscular atrophy","volume":"7","author":"Nlend Nlend","year":"2010","journal-title":"RNA Biol"},{"key":"10.1016\/j.gde.2013.03.003_bib0205","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1093\/nar\/gkr152","article-title":"Design principles for bifunctional targeted oligonucleotide enhancers of splicing","volume":"39","author":"Owen","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gde.2013.03.003_bib0210","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/hmg\/ddq094","article-title":"Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN\/Smn splicing","volume":"19","author":"Mende","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0215","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/hmg\/ddn357","article-title":"Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition","volume":"18","author":"Hauke","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0220","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy","volume":"12","author":"Brichta","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0225","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1093\/hmg\/ddp313","article-title":"LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate","volume":"18","author":"Garbes","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0230","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1471-4159.2006.03868.x","article-title":"In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy","volume":"98","author":"Hahnen","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.gde.2013.03.003_bib0235","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"Sumner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2013.03.003_bib0240","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI29562","article-title":"Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy","volume":"117","author":"Avila","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gde.2013.03.003_bib0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00439-006-0186-1","article-title":"The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA\/protein levels in spinal muscular atrophy cells","volume":"120","author":"Riessland","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.gde.2013.03.003_sbref0250","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/hmg\/ddq023","article-title":"SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy","volume":"19","author":"Riessland","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_sbref0255","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/hmg\/dds437","article-title":"VPA response in SMA is suppressed by the fatty acid translocase CD36","volume":"22","author":"Garbes","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0260","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/MCB.01262-08","article-title":"Regulation of SMN protein stability","volume":"29","author":"Burnett","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.gde.2013.03.003_bib0265","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1093\/hmg\/ddr288","article-title":"Increasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in mice","volume":"20","author":"Kwon","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0270","doi-asserted-by":"crossref","first-page":"e1000773","DOI":"10.1371\/journal.pgen.1000773","article-title":"Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy","volume":"5","author":"Baumer","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0275","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2008.03.031","article-title":"SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing","volume":"133","author":"Zhang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.gde.2013.03.003_bib0400","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1093\/hmg\/ddq147","article-title":"Spinal muscular atrophy: mechanisms and therapeutic strategies","volume":"19","author":"Lorson","year":"2010","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.gde.2013.03.003_bib0285","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.gde.2013.03.003_bib0290","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","article-title":"A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse","volume":"21","author":"Porensky","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0295","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"Dominguez","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0300","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0896-6273(03)00633-0","article-title":"Cytoskeletal dynamics and transport in growth cone motility and axon guidance","volume":"40","author":"Dent","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2013.03.003_bib0305","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1523\/JNEUROSCI.5808-11.2012","article-title":"Survival motor neuron affects plastin 3 protein levels leading to motor defects","volume":"32","author":"Hao le","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.gde.2013.03.003_sbref0310","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/hmg\/dds540","article-title":"Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality","volume":"122","author":"Ackermann","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0315","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/hmg\/ddq021","article-title":"Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model","volume":"19","author":"Bowerman","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0320","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0325","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ng.2479","article-title":"Digenic inheritance and Mendelian disease","volume":"44","author":"Lupski","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0330","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s11248-011-9496-8","article-title":"Disruption of the survival motor neuron (SMN) gene in pigs using ssDNA","volume":"20","author":"Lorson","year":"2011","journal-title":"Transgenic Res"},{"key":"10.1016\/j.gde.2013.03.003_bib0335","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/hmg\/9.5.849","article-title":"Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy","volume":"9","author":"Frugier","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0340","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.200303168","article-title":"Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding","volume":"162","author":"McWhorter","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.gde.2013.03.003_bib0405","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/dneu.20912","article-title":"Synaptic defects in spinal muscular atrophy animal models","volume":"72","author":"Torres-Benito","year":"2012","journal-title":"Dev Neurobiol."},{"key":"10.1016\/j.gde.2013.03.003_bib0350","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nmd.2011.09.007","article-title":"A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology","volume":"22","author":"Bowerman","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.gde.2013.03.003_bib0355","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.nmd.2011.10.021","article-title":"Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy","volume":"22","author":"Somers","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.gde.2013.03.003_bib0360","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/mus.21654","article-title":"Digital necroses and vascular thrombosis in severe spinal muscular atrophy","volume":"42","author":"Rudnik-Schoneborn","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.gde.2013.03.003_bib0365","article-title":"Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585","author":"Schreml","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0370","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0002-9440(10)63428-1","article-title":"Deletion of murine Smn exon 7 directed to liver leads to severe defect of liver development associated with iron overload","volume":"165","author":"Vitte","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gde.2013.03.003_bib0375","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.152.5.1107","article-title":"Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy","volume":"152","author":"Cifuentes-Diaz","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.gde.2013.03.003_bib0380","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/4.10.1927","article-title":"Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals","volume":"4","author":"Hahnen","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0385","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/hmg\/9.16.2451","article-title":"Animal models of spinal muscular atrophy","volume":"9","author":"Monani","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0390","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/hmg\/ddr046","article-title":"The COPI vesicle complex binds and moves with survival motor neuron within axons","volume":"20","author":"Peter","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2013.03.003_bib0395","doi-asserted-by":"crossref","first-page":"e51826","DOI":"10.1371\/journal.pone.0051826","article-title":"The spinal muscular atrophy disease protein SMN is linked to the Golgi network","volume":"7","author":"Ting","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Current Opinion in Genetics & Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X13000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X13000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:43:47Z","timestamp":1760701427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959437X13000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0959437X13000464"],"URL":"https:\/\/doi.org\/10.1016\/j.gde.2013.03.003","relation":{},"ISSN":["0959-437X"],"issn-type":[{"value":"0959-437X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Genetics & Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gde.2013.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}